Emerging and Mechanism-Based Therapies for Recurrent or Metastatic Merkel Cell Carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Emerging and Mechanism-Based Therapies for Recurrent or Metastatic Merkel Cell Carcinoma

Published:2013-02-23 Issue:2 Volume:14 Page:249-263
ISSN:1527-2729
Container-title:Current Treatment Options in Oncology
language:en
Short-container-title:Curr. Treat. Options in Oncol.

Author:

Miller Natalie J.,Bhatia Shailender,Parvathaneni Upendra,Iyer Jayasri G.,Nghiem Paul

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11864-013-0225-9.pdf

Reference84 articles.

1. Albores-Saavedra J, Batich K, Chable-Montero F, et al. Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study. J Cutan Pathol. 2010;37(1):20–7.

2. Heath M, Jaimes N, Lemos B, et al. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. J Am Acad Dermatol. 2008;58(3):375–81.

3. Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science. 2008;319(5866):1096–100.

4. Shuda M, Feng H, Kwun HJ, et al. T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus. Proc Natl Acad Sci U S A. 2008;105(42):16272–7.

5. Arora R, Shuda M, Guastafierro A, et al. Survivin is a therapeutic target in Merkel cell carcinoma. Sci Transl Med. 2012;4(133):1–11.

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Evaluation and Treatment of Merkel Cell Carcinoma and Brain Metastasis: A Case Report and Review of the Literature;Cureus;2023-12-29

2. Merkel cell carcinoma: epidemiology, clinical features, diagnosis and treatment of a rare disease;Anais Brasileiros de Dermatologia;2023-05

3. Eyelid and Periocular Cutaneous Carcinomas;Albert and Jakobiec's Principles and Practice of Ophthalmology;2022

4. The prognostic significance of PD-L1 expression on tumor and immune cells in Merkel cell carcinoma;Journal of Cancer Research and Clinical Oncology;2021-06-11

5. Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma;Journal for ImmunoTherapy of Cancer;2021-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3